OptiNose, Inc.
General ticker "OPTN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $80.1M (TTM average)
OptiNose, Inc. does not follow the US Stock Market performance with the rate: -30.4%.
Estimated limits based on current volatility of 0.8%: low 9.44$, high 9.59$
Factors to consider:
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.81$, 10.82$]
- 2025-12-31 to 2026-12-31 estimated range: [3.32$, 11.33$]
Financial Metrics affecting the OPTN estimates:
- Negative: Non-GAAP EPS, $ of -2.88 <= 0.04
- Negative: Operating cash flow per share per price, % of -0.06 <= 1.79
- Negative: negative Net income
- Negative: negative Operating income
- Negative: Industry earnings per price (median), % of -14.90 <= 0
- Negative: Shareholder equity ratio, % of -31.34 <= 22.52
- Negative: negative Industry operating income (median)
- Positive: Interest expense per share, $ of 0 <= 0.10
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term OPTN quotes
Long-term OPTN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $76.28MM | $70.99MM | $78.23MM |
| Operating Expenses | $132.17MM | $93.73MM | $94.55MM |
| Operating Income | $-55.90MM | $-22.75MM | $-16.32MM |
| Non-Operating Income | $-18.94MM | $-12.73MM | $-5.22MM |
| Interest Expense | $16.84MM | $19.53MM | $20.06MM |
| R&D Expense | $15.26MM | $5.30MM | $3.85MM |
| Income(Loss) | $-74.83MM | $-35.48MM | $-21.54MM |
| Profit(Loss)* | $-76.39MM | $-35.48MM | $-21.54MM |
| Stockholders Equity | $-56.62MM | $-86.61MM | $-40.36MM |
| Inventory | $9.44MM | $8.05MM | $11.46MM |
| Assets | $144.22MM | $107.73MM | $128.78MM |
| Operating Cash Flow | $-67.65MM | $-20.53MM | $-44.89MM |
| Capital expenditure | $0.06MM | $0.33MM | $0.07MM |
| Investing Cash Flow | $-0.06MM | $-0.33MM | $-0.07MM |
| Financing Cash Flow | $51.44MM | $0.30MM | $55.55MM |
| Earnings Per Share** | $-0.89 | $-0.32 | $-2.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.